| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |